Overview
Availability
- Dr Greg Bourne is:
- Available for supervision
Fields of research
Qualifications
- Bachelor (Honours) of Science (Advanced), The University of Queensland
- Doctor of Philosophy, University of Cambridge
Works
Search Professor Greg Bourne’s works on UQ eSpace
2024
Other Outputs
Peptide Inhibitors of Interleukin-23 Receptor
Barros, Stephanie A., Neelamkavil, Santhosh Francis, Sun, Chengzao, Guo, Boying, Hendrick, Charles, Marcoux, David, Somani, Sandeep, Thieu, Tho, Zhang, Jing, Branca, Danila, Costante, Roberto, Bhandari, Ashok, Bourne, Gregory Thomas and Frederick, Brian Troy (2024). Peptide Inhibitors of Interleukin-23 Receptor. US20240279281.
2024
Other Outputs
Peptide inhibitors of interleukin-23 receptor
Barros Stephanie A., Neelamkavil, Santhosh Francis, Sun, Chengzao, Hendrick, Charles, Patch, Raymond J., Somani, Sandeep, Zhang, Jing, Bianchi, Elisabetta, Branca, Danila, Costante, Roberto, Costantini, Willy, Ingenito, Raffaele, Lollobrigida, Martina, Rinaldi, Antonia, Bhandari, Ashok, Bourne, Gregory Thomas and Frederick, Brian Troy (2024). Peptide inhibitors of interleukin-23 receptor . WO2024155547A2.
2024
Other Outputs
Peptide inhibitors of interleukin-23 receptor
Barros Stephanie A., Neelamkavil, Santhosh Francis, Sun, Chengzao, Guo, Boying, Hendrick, Charles, Marcoux, David, Somani, Sandeep, Thieu, Tho, Zhang, Jing, Branca, Danila, Costante, Roberto, Bhandari, Ashok, Bourne, Gregory Thomas and Frederick, Brian Troy (2024). Peptide inhibitors of interleukin-23 receptor. WO2024155546A1.
2023
Conference Publication
Iron restricted erythropoiesis under hepcidin mimetic treatment (PN23114) improved disease parameters in a mouse model for sickle cell disease
Taranath, Roopa, Zhao, Li, Bourne, Gregory, Bhatt, Ramesh R., Plevy, Scott, Liu, David Y. and Bhandari, Ashok (2023). Iron restricted erythropoiesis under hepcidin mimetic treatment (PN23114) improved disease parameters in a mouse model for sickle cell disease. 65th Annual Meeting of the American Society of Hematology (ASH), San Diego, CA, United States, 9-12 December 2023. Washington, DC, United States: American Society of Hematology. doi: 10.1182/blood-2023-182472
2023
Other Outputs
Hepcidin mimetics for treatment of sickle cell disease
Liu, David Y., Bourne, Gregory Thomas, Taranath, Roopa and Zhao, Li (2023). Hepcidin mimetics for treatment of sickle cell disease. WO2023240077A1.
2023
Other Outputs
Conjugated hepcidin mimetics
Bourne, Gregory Thomas, Bhandari, Ashok, Zhang, Jie, Smythe, Mark Leslie and Taranath, Roopa (2023). Conjugated hepcidin mimetics. WO2023150630A2.
2022
Other Outputs
Conjugated hepcidin mimetics
Bhandari, Ashok, Zhang, Jie, Bourne, Gregory Thomas, Smythe, Mark Leslie, Tran, Tran Trung and Taranath, Roopa (2022). Conjugated hepcidin mimetics. WO2022212696A1.
2022
Other Outputs
Conjugated hepcidin mimetics
Bourne, Gregory Thomas, Bhandari, Ashok, Zhang, Jie and Smythe, Mark Leslie (2022). Conjugated hepcidin mimetics. WO2023150618A2.
2021
Other Outputs
Conjugated hepcidin mimetics
Bourne, Gregory Thomas, Bhandari, Ashok, Zhang, Jie, Frederick, Brian Troy and Smythe, Mark Leslie (2021). Conjugated hepcidin mimetics. WO2022026629A1.
2021
Other Outputs
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
Sun, Chengzao, Frederick, Brian Troy, Somani, Sandeep, Bourne, Gregory Thomas, Patch, Raymond, Bhandari, Ashok, Ingenito, Raffaele, Costante, Roberto, Branca, Danila and Bianchi, Elisabetta (2021). Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases. WO2021146441A1.
2021
Other Outputs
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
Bhandari, Ashok, Frederick, Brian Troy, Tran, Tran Trung and Bourne, Gregory Thomas (2021). Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases. WO2021146458.
2020
Conference Publication
Hepcidin peptidomimetics - oral efficacy in pre-clinical disease model of iron overload
Taranath, Roopa, Bourne, Gregory, Zhang, Jie, Frederick, Brian, Tran, Tran T., Bhandari, Ashok, Vengalam, Jayanthi, McMahon, Jaimee, Huie, Keith, Ledet, Grace A., Zhao, Li, Tovera, James, Lee, Larry, Yang, Bo, Dion, Celino, Yuan, Lucy, Zemede, Genet, Nguyen, Michelle, Masjedizadeh, Mohammad, Cheng, Xiaoli, Mattheakis, Larry, Liu, David and Smythe, Mark L. (2020). Hepcidin peptidomimetics - oral efficacy in pre-clinical disease model of iron overload. 62nd Annual Meeting of the American Society of Hematology (ASH), Virtual, 5-8 December 2020. Washington, DC, United States: American Society of Hematology. doi: 10.1182/blood-2020-141720
2020
Other Outputs
Conjugated hepcidin mimetics
Liu, David Y., Bourne, Gregory Thomas, Taranath, Roopa, Gupta, Suneel Kumar and Modi, Nishit Bachulal (2020). Conjugated hepcidin mimetics. WO2021046246A1.
2020
Other Outputs
Conjugated hepcidin mimetics
Liu, David Y., Bourne, Gregory Thomas, Taranath, Roopa, Gupta, Suneel Kumar and Modi, Nishit Bachulal (2020). Conjugated hepcidin mimetics. WO2021046246.
2019
Other Outputs
Conjugated hepcidin mimetics
Bourne, Gregory Thomas, Bhandari, Ashok, Frederick, Brian Troy, Zhang, Jie, Stephenson, Adam, Smythe, Mark Leslie, Taranath, Roopa and Liu, David (2019). Conjugated hepcidin mimetics. WO2019157268.
2018
Other Outputs
Opioid agonist peptides and uses thereof
Anandan, Sampath Kumar, Zhang, Jie, Bhandari, Ashok, Bourne, Gregory Thomas and Frederick, Brian Troy (2018). Opioid agonist peptides and uses thereof. WO2019051494A1.
2018
Conference Publication
Oral delivery of peptides with dual mu/delta opioid receptor agonist activities are superior to eluxadoline in preclinical models of IBS-D
Mattheakis, Larry, Anandan, Sampath-Kumar, Zhao, Li, Zerangue, Noa, Zhang, Jenny, Bourne, Greg T., Shah, Shairaz, Foulke, Matthew, Vinh Tran,, Tovera, James, Bai, Lu, Taranath, Roopa, Stephenson, Adam, Annamalai, Thamil, Bhandari, Ashok and Liu, David Y. (2018). Oral delivery of peptides with dual mu/delta opioid receptor agonist activities are superior to eluxadoline in preclinical models of IBS-D. Annual Meeting of the American Society for Gastrointestinal Endoscopy / Digestive Disease Week, Washington, DC, United States, 2-5 June 2018. Philadelphia, PA, United States: Elsevier.
2018
Other Outputs
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
Bhandari, Ashok and Bourne, Gregory (2018). Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases. WO2018136646A1.
2017
Conference Publication
Hepcidin Mimetic Ptg-300 for Treatment of Ineffective Erythropoiesis and Iron Overload
Bourne, Gregory, Zhao, Li, Bhandari, Ashok, Frederick, Brian, McMahon, Jaimee, Tran, Vinh, Zhang, Jenny, Stephenson, Adam, Tovera, James, Bai, Lu, Annamalai, Thamil, Patel, Dinesh, Smythe, Mark and Liu, David (2017). Hepcidin Mimetic Ptg-300 for Treatment of Ineffective Erythropoiesis and Iron Overload. Seventh Congress of the International BioIron Society (IBIS)Biennial World Meeting (BioIron 2017), Los Angeles, CA, United States, 7 - 11 May 2017. Hoboken, NJ United States: Wiley.
2016
Other Outputs
Analogues of hepcidin mimetics with improved in vivo half lives
Bourne, Gregory Thomas, Smythe, Mark Leslie, Frederick, Brian Troy and Bhandari, Ashok (2016). Analogues of hepcidin mimetics with improved in vivo half lives. WO2017117411A1.
Funding
Past funding
Supervision
Availability
- Dr Greg Bourne is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Media
Enquiries
For media enquiries about Dr Greg Bourne's areas of expertise, story ideas and help finding experts, contact our Media team: